HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,290,579 | +7.0% | 14,407 | +1.7% | 0.01% | +10.0% |
| Q2 2023 | $1,206,434 | -0.6% | 14,170 | -3.4% | 0.01% | -9.1% |
| Q1 2023 | $1,213,446 | +6.5% | 14,664 | +1.3% | 0.01% | 0.0% |
| Q4 2022 | $1,138,852 | +10.4% | 14,480 | +3.9% | 0.01% | 0.0% |
| Q3 2022 | $1,032,000 | +14.3% | 13,934 | +0.6% | 0.01% | +22.2% |
| Q2 2022 | $903,000 | +3.4% | 13,851 | +0.3% | 0.01% | +28.6% |
| Q1 2022 | $873,000 | +19.9% | 13,815 | +0.6% | 0.01% | +16.7% |
| Q4 2021 | $728,000 | -25.5% | 13,734 | -0.8% | 0.01% | -25.0% |
| Q3 2021 | $977,000 | +6.1% | 13,843 | +0.2% | 0.01% | +14.3% |
| Q2 2021 | $921,000 | -43.9% | 13,815 | -6.5% | 0.01% | -50.0% |
| Q1 2021 | $1,641,000 | -6.0% | 14,781 | +0.5% | 0.01% | -12.5% |
| Q4 2020 | $1,746,000 | +31.7% | 14,703 | -3.3% | 0.02% | +23.1% |
| Q3 2020 | $1,326,000 | +30.4% | 15,203 | +33.9% | 0.01% | -7.1% |
| Q2 2020 | $1,017,000 | -14.2% | 11,353 | -4.6% | 0.01% | -30.0% |
| Q1 2020 | $1,186,000 | -64.1% | 11,899 | -58.6% | 0.02% | -50.0% |
| Q4 2019 | $3,302,000 | -17.3% | 28,741 | -9.2% | 0.04% | -18.4% |
| Q3 2019 | $3,991,000 | -10.8% | 31,642 | -14.9% | 0.05% | -5.8% |
| Q2 2019 | $4,472,000 | +39.6% | 37,164 | +1.5% | 0.05% | +36.8% |
| Q1 2019 | $3,204,000 | -13.7% | 36,626 | -1.3% | 0.04% | -20.8% |
| Q4 2018 | $3,711,000 | -11.8% | 37,096 | +1.1% | 0.05% | +20.0% |
| Q3 2018 | $4,206,000 | +29.4% | 36,704 | +1.3% | 0.04% | +21.2% |
| Q2 2018 | $3,251,000 | -47.3% | 36,246 | -57.0% | 0.03% | -46.8% |
| Q1 2018 | $6,166,000 | +19.6% | 84,275 | -5.1% | 0.06% | +24.0% |
| Q4 2017 | $5,156,000 | +320.9% | 88,775 | +225.2% | 0.05% | +233.3% |
| Q3 2017 | $1,225,000 | +13.2% | 27,297 | -0.4% | 0.02% | 0.0% |
| Q2 2017 | $1,082,000 | -1.5% | 27,397 | +1.1% | 0.02% | 0.0% |
| Q1 2017 | $1,099,000 | +2.8% | 27,097 | +1.9% | 0.02% | -6.2% |
| Q4 2016 | $1,069,000 | +11.5% | 26,597 | +0.4% | 0.02% | +6.7% |
| Q3 2016 | $959,000 | +24.9% | 26,497 | 0.0% | 0.02% | +36.4% |
| Q2 2016 | $768,000 | -15.9% | 26,497 | +1.5% | 0.01% | -8.3% |
| Q1 2016 | $913,000 | +12.9% | 26,097 | +4.0% | 0.01% | +9.1% |
| Q4 2015 | $809,000 | +2.5% | 25,097 | +2.9% | 0.01% | 0.0% |
| Q3 2015 | $789,000 | -41.3% | 24,397 | -32.0% | 0.01% | -31.2% |
| Q4 2014 | $1,343,000 | +7.8% | 35,898 | +0.6% | 0.02% | +6.7% |
| Q3 2014 | $1,246,000 | -6.5% | 35,698 | -5.6% | 0.02% | -6.2% |
| Q2 2014 | $1,333,000 | +10.0% | 37,798 | +1.6% | 0.02% | +6.7% |
| Q1 2014 | $1,212,000 | -29.8% | 37,198 | -9.3% | 0.02% | -28.6% |
| Q4 2013 | $1,727,000 | -5.8% | 40,998 | -10.9% | 0.02% | -8.7% |
| Q3 2013 | $1,834,000 | -3.8% | 45,998 | -0.2% | 0.02% | -11.5% |
| Q2 2013 | $1,906,000 | -1.1% | 46,098 | -0.4% | 0.03% | -7.1% |
| Q1 2013 | $1,928,000 | – | 46,298 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |